Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
clinical trials
duchenne muscular dystrophy
dyne therapeutics
event
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life science
muscular dystrophy
myotonic dystrophy type 1
national
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
early
2
×
accelerating
ago
attend
biopharma's
biopharma’s
biotechs
bird
boston
breakthroughs
considering
data
digital
diseases
drug
dyne
ends
expected
experimental
eyes
future
genetic
having
health
humans
ipo
ipos
learn
life
long
medical
medicines
muscle
rare
reach
registering
sciences
team
tech
therapeutics
Language
unset
Current search:
boston
×
early
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health